FOR-COVID

Bavarian consortium for research on the pandemic disease COVID-19 (FOR-COVID)

Active and passive immunization, analysis of the human immune response

The broad use of protective vaccines is the only option to efficiently halt the global suffering caused by SARS-CoV-2 infection. Therefore, continuous advancements in the design and continued development of vaccines are needed to combat the ongoing pandemic.
Additionally, a profound knowledge of the breadth and durability of SARS-CoV-2 specific immune responses after viral infection as well a after vaccination is essential to address the pandemic. 
With the considerable evolution of SARS-CoV-2 and the emergence of VoCs it will be of special significance to characterize the mutations and their impact in the efficacy of vaccines, transmissibility and immune escape.

 

Projects

  • Expanding immunity against SARS-CoV-2 by vaccination
    more
  • T cell antigens for new multivalent vector vaccines against SARS-CoV-2-like coronaviruses
    more
  • Strength and durability of immune respones SARS-CoV-2 infection and vaccination
    more
  • Projekt im Forschungsnetz Sachsen-Bayern: Analyse und Modulation von angeborener und erworbener Immunität bei SARS-CoV2 Infektion
    more
  • Charakterisierung von SARS-CoV-2 Varianten die Immunantworten ausweichen
    more
  • Projekt im Forschungsnetz Sachsen-Bayern: Formierung, klinisches Management und Langzeit-Follow-up einer Saechsischen COVID-19-Kohorte (SaCCo)
    more

Information

Launching date

10.2020

End

12.2024

Funded by

Bavarian State Ministry of Science and the Arts